Initial evidence of endothelial cell apoptosis as a mechanism of systemic capillary leak syndrome

被引:71
作者
Assaly, R
Olson, D
Hammersley, J
Fan, PS
Liu, J
Shapiro, JI
Kahaleh, MB
机构
[1] Med Coll Ohio, Dept Med, Div Rheumatol, Toledo, OH 43614 USA
[2] Med Coll Ohio, Dept Pharmacol, Toledo, OH 43614 USA
关键词
apoptosis; capillary leak; endothelial cell;
D O I
10.1378/chest.120.4.1301
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
Background: Systemic capillary leak syndrome (SCLS) is a rare disorder of unknown etiology that is characterized by acute recurrent attacks of hypovolemic shock commonly following an inflammatory stimulus such as a viral illness. Prophylactic therapy is generally, ineffective, and the outcome is frequently fatal. Methods: In order to investigate the cellular mechanisms leading to SCLS, we examined the effects of sera from two patients with active SCLS on microvascular endothelial cell apoptosis in vitro. Apoptosis was determined by morphologic criteria, DNA fragmentation, annexin V stain, and by a quantitative photometric assay. The apoptotic pathway was investigated by Western blot of endothelial cells lysate after exposure to SCLS sera. Results: The sera from patients with active SCLS mediated profound apoptosis of microvascular endothelial cells shortly after exposure. The exposed microvascular endothelial cells underwent immediate apoptosis as evidenced by morphologic changes, plasma membrane phosphatidylserine exposure, and by DNA fragmentation. Increased Bax/Bcl-2 ratio in endothelial cells exposed to SCLS sera was observed and suggested an oxidation injury as the possible mechanism for endothelial apoptosis. This potential mechanism was further explored by measuring intracellular reactive oxygen species (ROS) following SCLS serum exposure. Sera from both patients caused marked increases in ROS, initially detectable at 1 h and persisted for at least 12 h, with control serum from healthy subjects showing no effect on basal endothelial cell ROS concentrations. Conclusion: Components from the sera of patients with active systemic capillary leak syndrome in contrast to healthy subject sera mediate early, and extensive endothelial apoptosis in vitro that is associated with oxidation injury. These data represent compelling initial evidence for oxidation-induced apoptosis as a likely mechanism for endothelial injury, leading to SCLS.
引用
收藏
页码:1301 / 1308
页数:8
相关论文
共 26 条
[1]
SYSTEMIC CAPILLARY LEAK SYNDROME AND MONOCLONAL IGG GAMMOPATHY - STUDIES IN A 6TH PATIENT AND A REVIEW OF LITERATURE [J].
ATKINSON, JP ;
WALDMANN, TA ;
STEIN, SF ;
GELFAND, JA ;
MACDONALD, WJ ;
HECK, LW ;
COHEN, EL ;
KAPLAN, AP ;
FRANK, MM .
MEDICINE, 1977, 56 (03) :225-239
[2]
Idiopathic capillary leak syndrome: Evidence of CD8-positive lymphocytes surrounding damaged endothelial cells [J].
Cicardi, M ;
Berti, E ;
Caputo, V ;
Radice, F ;
Gardinali, M ;
Agostoni, A .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (03) :417-419
[3]
THE SYSTEMIC CAPILLARY LEAK SYNDROME - APPEARANCE OF INTERLEUKIN-2-RECEPTOR-POSITIVE CELLS DURING ATTACKS [J].
CICARDI, M ;
GARDINALI, M ;
BISIANI, G ;
ROSTI, A ;
ALLAVENA, P ;
AGOSTONI, A .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (06) :475-477
[4]
CYCLICAL EDEMA AND SHOCK DUE TO INCREASED CAPILLARY PERMEABILITY [J].
CLARKSON, B ;
THOMPSON, D ;
HORWITH, M ;
LUCKEY, EH .
AMERICAN JOURNAL OF MEDICINE, 1960, 29 (02) :193-216
[5]
Aminothiols protect endothelial cell proliferation against inhibition by lipopolysaccharide [J].
Drab-Weiss, EA ;
Hansra, IK ;
Blazek, ER ;
Rubin, DB .
SHOCK, 1998, 10 (06) :423-429
[6]
CONTROL OF SYSTEMIC CAPILLARY LEAK SYNDROME WITH AMINOPHYLLINE AND TERBUTALINE [J].
DRODER, RM ;
KYLE, RA ;
GREIPP, PR .
AMERICAN JOURNAL OF MEDICINE, 1992, 92 (05) :523-526
[7]
FADOK VA, 1992, J IMMUNOL, V148, P2207
[8]
Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation [J].
HaimovitzFriedman, A ;
CordonCardo, C ;
Bayoumy, S ;
Garzotto, M ;
McLoughlin, M ;
Gallily, R ;
Edwards, CK ;
Schuchman, EH ;
Fuks, Z ;
Kolesnick, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (11) :1831-1841
[9]
BCL-2 IS AN INNER MITOCHONDRIAL-MEMBRANE PROTEIN THAT BLOCKS PROGRAMMED CELL-DEATH [J].
HOCKENBERY, D ;
NUNEZ, G ;
MILLIMAN, C ;
SCHREIBER, RD ;
KORSMEYER, SJ .
NATURE, 1990, 348 (6299) :334-336
[10]
PERIODIC DISEASE ASSOCIATED WITH MUSCLE DESTRUCTION [J].
JACOX, RF ;
WATERHOUSE, C ;
TOBIN, R .
AMERICAN JOURNAL OF MEDICINE, 1973, 55 (01) :105-110